PT584 – How Psychedelics Impact the Mind: Mys...

This is an important discussion about harms, and what we should be doing about them. Josh and Roman are working on a major study at Emory University to answer some of the basic and outstanding questions we have about psychedelic risks and cases that can be challenging to recover ...  عرض المزيد

This is a special episode featuring two of our favorite organizations. DanceSafe and Shulgin Foundation. Listen to Joe Moore record with the heads of these orgs and learn about how you may be able to buy some art to support them. This is a singularly important history and partner ...  عرض المزيد

In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ...  عرض المزيد

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and L ...  عرض المزيد

Psychiatrist and psychedelics and bipolar researcher Dr. Josh Woolley (University of California San Francisco), and peer researcher Amir speak on psilocybin, ketamine, and psychedelics and their links with bipolar disorder, and what the science says about psychedelics as treat ...

<span style= "font-size: 10.0pt; mso-bidi-font-family: Arial; mso-bidi-font-style: italic;"> What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributa ...